From Gonocytes to Testicular Cancer

Abstract: Testicular germ‐cell tumors occur primarily in young individuals, and the tumors in this age group (seminomas or nonseminomas) are derived from a preinvasive precursor cell called carcinoma in situ (CIS) or intratubular germ‐cell neoplasia. These tumors have been a growing problem, especially in highly developed industrialized countries. A hypothesis was put forward that CIS originates from arrested fetal germ cells, thus testicular cancer is a developmental disease of germ‐cell differentiation. This notion was supported by comparative studies of the gene expression at the protein and RNA level, which demonstrated a close similarity of CIS to primordial germ cells and gonocytes with many features of embryonic stem cells. The arrest of germ‐cell differentiation is thus the key first event, which may be followed by malignant transformation and overt germ‐cell cancer in young adult age, usually after puberty. In most cases the arrest/delay of germ‐cell differentiation is caused by testicular dysgenesis, a multifactorial and complex syndrome that has a broad spectrum of phenotypes ranging from moderate impairment of spermatogenesis to severe disorders of sexual development and differentiation. The most severe cases are a result of inherited genetic aberrations, but the etiology of the common sporadic testicular cancer must involve environmental factors, including maternal lifestyle and possibly an early exposure to endocrine disruptors. The effects of environmental factors are likely modulated by genomic variation (polymorphisms), thus explaining the individual susceptibility and population‐level differences in the incidence of testicular cancer.

[1]  K. Michels,et al.  Birth weight and the risk of testicular cancer: A meta‐analysis , 2007, International journal of cancer.

[2]  N. Skakkebaek,et al.  DNA damage response in human testes and testicular germ cell tumours: biology and implications for therapy. , 2007, International journal of andrology.

[3]  R. Sharpe,et al.  Role of androgens in fetal testis development and dysgenesis. , 2007, Endocrinology.

[4]  D. Veeramachaneni,et al.  Sequelae in male rabbits following developmental exposure to p,p'-DDT or a mixture of p,p'-DDT and vinclozolin: cryptorchidism, germ cell atypia, and sexual dysfunction. , 2007, Reproductive toxicology.

[5]  N. Skakkebæk,et al.  ORIGIN OF TESTICULAR GERM CELL NEOPLASIA: THE ROLE OF SEX CHROMOSOMES , 2007 .

[6]  Yun-Fai Chris Lau,et al.  Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ. , 2007, Urologic oncology.

[7]  P. Andrews,et al.  Adaptation to culture of human embryonic stem cells and oncogenesis in vivo , 2007, Nature Biotechnology.

[8]  J. Korkola,et al.  Biology and genetics of adult male germ cell tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Ferlay,et al.  Interpreting the international trends in testicular seminoma and nonseminoma incidence , 2006, Nature Clinical Practice Urology.

[10]  L. Looijenga,et al.  Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. , 2006, Endocrine reviews.

[11]  J. Rossant,et al.  Retinoid Signaling Determines Germ Cell Fate in Mice , 2006, Science.

[12]  D. Solter,et al.  From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research , 2006, Nature Reviews Genetics.

[13]  N. Skakkebaek,et al.  Low Birth Weight and Male Reproductive Function , 2006, Hormone Research in Paediatrics.

[14]  E. Rajpert-De Meyts,et al.  Testicular development in the complete androgen insensitivity syndrome , 2006, The Journal of pathology.

[15]  David C Page,et al.  Retinoic acid regulates sex-specific timing of meiotic initiation in mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Eriksson,et al.  In utero exposure to persistent organic pollutants in relation to testicular cancer risk. , 2006, International journal of andrology.

[17]  J. Furr,et al.  Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals. , 2006, International journal of andrology.

[18]  M. Pike,et al.  The Y deletion gr/gr and susceptibility to testicular germ cell tumor. , 2005, American journal of human genetics.

[19]  A. Hart,et al.  The pluripotency homeobox gene NANOG is expressed in human germ cell tumors , 2005, Cancer.

[20]  A. Chakravarti,et al.  Genomic alterations in cultured human embryonic stem cells , 2005, Nature Genetics.

[21]  E. Steyerberg,et al.  Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. , 2005, The Journal of clinical endocrinology and metabolism.

[22]  S. Schwartz,et al.  Risk of Testicular Germ Cell Cancer in Relation to Variation in Maternal and Offspring Cytochrome P450 Genes Involved in Catechol Estrogen Metabolism , 2005, Cancer Epidemiology Biomarkers & Prevention.

[23]  A. Roverato,et al.  Molecular analysis of the androgen receptor gene in testicular cancer. , 2005, Endocrine-related cancer.

[24]  A. Sigurdson,et al.  International patterns and trends in testis cancer incidence , 2005, International journal of cancer.

[25]  R. Lothe,et al.  Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. , 2005, Cancer research.

[26]  I. Skoneczna,et al.  CAG repeat polymorphism in the DNA polymerase gamma gene in a Polish population: an association with testicular cancer risk. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  H. Leffers,et al.  Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours , 2005, Histopathology.

[28]  E. Wardelmann,et al.  Transcription factor AP‐2γ, a novel marker of gonocytes and seminomatous germ cell tumors , 2005, International journal of cancer.

[29]  R. Kruse,et al.  Decrease in Anogenital Distance among Male Infants with Prenatal Phthalate Exposure , 2005, Environmental health perspectives.

[30]  J. Bartek,et al.  ATM Activation in Normal Human Tissues and Testicular Cancer , 2005, Cell cycle.

[31]  H. Leffers,et al.  Transcription Factor AP-2γ Is a Developmentally Regulated Marker of Testicular Carcinoma In situ and Germ Cell Tumors , 2004, Clinical Cancer Research.

[32]  H. Adami,et al.  Testicular cancer incidence in eight northern European countries: secular and recent trends. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  P. Saunders,et al.  Immunohistochemical Profiling of Germ Cells Within the Human Fetal Testis: Identification of Three Subpopulations , 2004, Biology of reproduction.

[34]  Christian Schwager,et al.  Embryonic Stem Cell-Like Features of Testicular Carcinoma in Situ Revealed by Genome-Wide Gene Expression Profiling , 2004, Cancer Research.

[35]  C. Bokemeyer,et al.  Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells , 2004, The Journal of pathology.

[36]  N. Skakkebaek,et al.  Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. , 2004, Human reproduction.

[37]  U. Pichlmeier,et al.  Clinical epidemiology of testicular germ cell tumors , 2004, World Journal of Urology.

[38]  A. Clark,et al.  Human STELLAR, NANOG, and GDF3 Genes Are Expressed in Pluripotent Cells and Map to Chromosome 12p13, a Hotspot for Teratocarcinoma , 2004, Stem cells.

[39]  Y. Bergman,et al.  Oct-3/4 is a dose-dependent oncogenic fate determinant. , 2003, Cancer cell.

[40]  P. Brown,et al.  Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  N. Skakkebaek,et al.  Increased risk of carcinoma in situ in patients with testicular germ cell cancer with ultrasonic microlithiasis in the contralateral testicle. , 2003, The Journal of urology.

[42]  J. Masters,et al.  Curing metastatic cancer: lessons from testicular germ-cell tumours , 2003, Nature Reviews Cancer.

[43]  N. Skakkebaek,et al.  Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer , 2003, The Journal of pathology.

[44]  F. Granath,et al.  Body size at birth and adulthood and the risk for germ-cell testicular cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[45]  T. Matsuda,et al.  Increasing incidence of testicular cancer worldwide: a review. , 2003, The Journal of urology.

[46]  J. Bartek,et al.  Deregulation of the RB pathway in human testicular germ cell tumours , 2003, The Journal of pathology.

[47]  E. D. de Vries,et al.  The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis‐inducing stimuli , 2003, The Journal of pathology.

[48]  J. Kononen,et al.  POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. , 2003, Cancer research.

[49]  J. Bartek,et al.  The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE‐A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma , 2003, Histopathology.

[50]  J. Bartek,et al.  The emerging phenotype of the testicular carcinoma in situ germ cell , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[51]  R. Sharpe,et al.  Environment, lifestyle and infertility--an inter-generational issue. , 2002, Nature cell biology.

[52]  R. Lothe,et al.  Genome profiles of familial/bilateral and sporadic testicular germ cell tumors , 2002, Genes, chromosomes & cancer.

[53]  R. Lothe,et al.  New insights into testicular germ cell tumorigenesis from gene expression profiling. , 2002, Cancer research.

[54]  J. Bartek,et al.  Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours , 2001, Oncogene.

[55]  N. Skakkebaek,et al.  Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects , 2001, Human reproduction.

[56]  C. Bokemeyer,et al.  Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. , 2000, The American journal of pathology.

[57]  J. Bartek,et al.  Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis , 2000, Oncogene.

[58]  L D Marrett,et al.  Pre‐natal and peri‐natal exposures and risk of testicular germ‐cell cancer , 2000, International journal of cancer.

[59]  M. Amin,et al.  Atlas of Tumor Pathology: Tumors of the Testis, Adnexa, Spermatic Cord, and Scrotum 1999 , 2000 .

[60]  J. McKiernan,et al.  Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. , 1999, The Journal of urology.

[61]  N. Skakkebæk,et al.  Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[62]  V. Reuter,et al.  Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[63]  N. Skakkebaek,et al.  Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells , 1997, Histopathology.

[64]  Sharpe,et al.  Male reproductive health and environmental xenoestrogens. , 1996, Environmental health perspectives.

[65]  H. Møller,et al.  Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark , 1996, Cancer Causes & Control.

[66]  N. Skakkebæk,et al.  PROLONGED EXPRESSION OF THE c‐kit RECEPTOR IN GERM CELLS OF INTERSEX FETAL TESTES , 1996, The Journal of pathology.

[67]  N. Skakkebaek,et al.  Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[68]  P. Ramani,et al.  Testicular Intratubular Germ Cell Neoplasia in Children and Adolescents with Intersex , 1993, The American journal of surgical pathology.

[69]  A. J. Swerdlow,et al.  Prenatal and familial associations of testicular cancer. , 1987, British Journal of Cancer.

[70]  N. Skakkebaek,et al.  Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. , 1987, International journal of andrology.

[71]  N. Skakkebaek,et al.  Testicular carcinoma in situ in children with the androgen insensitivity (testicular feminisation) syndrome. , 1984, British medical journal.

[72]  N. B. Atkin,et al.  SPECIFIC CHROMOSOME CHANGE, i(12p), IN TESTICULAR TUMOURS? , 1982, The Lancet.

[73]  A. Sohval Testicular dysgenesis in relation to neoplasm of the testicle. , 1956, The Journal of urology.

[74]  H. Leffers,et al.  Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers. , 2007, Human reproduction.

[75]  R. Pfundt,et al.  Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. , 2006, Cancer research.

[76]  J. Thomson,et al.  Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells , 2004, Nature Biotechnology.

[77]  Niels Keiding,et al.  Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1,770 young men from the general population in five European countries. , 2004, American journal of epidemiology.

[78]  H. Leffers,et al.  Do environmental factors play a role in the aetiology of carcinoma in situ testis and the testicular dysgenesis syndrome? , 2004, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[79]  J. Richie Is there an increased incidence of contralateral testicular cancer in patients with intratesticular microlithiasis? , 2003, Journal of Urology.

[80]  N. Skakkebaek,et al.  Are male reproductive disorders a common entity? The testicular dysgenesis syndrome. , 2001, Annals of the New York Academy of Sciences.

[81]  N. Skakkebaek,et al.  Possible carcinoma-in-situ of the testis. , 1972, Lancet.